Compounded Semaglutide Cost and Access: A Practical Guide

Published Jun 2, 2026Updated Jun 2, 2026Last reviewed Jun 2, 2026

Author: HealthRX Editorial Team Medically reviewed by: Dr. Mark Halpern, MD (Internal Medicine, Obesity Medicine) Last updated: May 2026

Last October, a woman named Diane in Columbus, Ohio, sat down at her kitchen table with a calculator, her Blue Cross plan summary, and a yellow legal pad. She'd just come back from an obesity medicine consult where her doctor recommended Wegovy. Her BMI was 38. She had sleep apnea and borderline A1c. She was, on paper, a textbook candidate. Then she called her pharmacy. The quote: $1,349 for a 28-day supply. Her plan covered it, technically, but only after a $500 deductible and a specialty tier copay that worked out to $287 a month. "I did the math for a full year," Diane told me. "It was $3,444 just in copays, plus labs, plus the appointments. I almost didn't start."

Diane's story is not unusual. It's the norm. The cost of semaglutide therapy is the single biggest variable in whether a patient can stay on the drug long enough to see real results. The published trials (STEP-1, Wilding et al., NEJM 2021) show that most weight loss accrues over the first 60 to 68 weeks of therapy, with significant regain on discontinuation (STEP-4, Rubino et al., JAMA 2021). A patient who drops off at month four because of cost doesn't get 40% of the benefit. They get most of the side effects of titration and a fraction of the payoff. Cost is, in practical terms, a clinical variable.

This page is a plain-language guide to what semaglutide actually costs, what insurance does and doesn't cover, what compounded semaglutide costs at reputable telehealth providers, and what hidden costs patients should plan for. It is not a price comparison. It's an attempt to give you enough information to make a budget that survives contact with reality.

For background on what compounded semaglutide is and the regulatory framework, see the pillar guide.

What Branded Wegovy and Ozempic Actually Cost at the Pharmacy Counter

The list price for Wegovy in the United States is approximately $1,349 per 28-day supply at the maintenance dose. Ozempic carries a similar list price. These numbers have been stable for several years. They are set by Novo Nordisk and apply across pharmacies.

If you have commercial insurance and a covered indication, you'll typically pay between $25 and $200 per month after coverage kicks in. The spread is wide because plan designs vary enormously, and specialty tier drugs like Wegovy sit behind different cost-sharing structures depending on whether your employer picked a generous or a stingy formulary.

Here's where it gets frustrating.

Medicare Part D cannot cover Wegovy for weight management. Federal statute explicitly excludes coverage of weight-loss drugs under Part D. This exclusion has been debated in Congress repeatedly, but as of mid-2026, it remains in effect. If you're on Medicare and want semaglutide for weight management, you're paying cash or finding an alternative pathway. Medicare Part D does cover Ozempic for type 2 diabetes when you meet the indication.

Medicaid coverage varies by state. Some state programs cover Wegovy for adults meeting obesity criteria, some only for adolescents, some not at all. You need to check your specific state Medicaid formulary, and "check" means calling, not Googling, because formulary PDFs are frequently outdated.

The Manufacturer Savings Card Problem

Novo Nordisk runs a savings program for Wegovy that can reduce out-of-pocket cost for commercially insured patients to as low as $0 per month, with caps on total annual benefit. There's a similar card for Ozempic. These sound great until you read the fine print.

Eligibility is restricted to patients with commercial insurance that already covers the drug. If your plan doesn't cover Wegovy, the savings card doesn't help you. If you're uninsured, it doesn't help you. Novo Nordisk also operates a patient assistance program for patients meeting income criteria, but the threshold is restrictive and the application process is slow.

The boring truth about these programs: they help people who already have favorable coverage. The patient in the most expensive position, the cash-pay person without insurance and without eligibility for assistance, is exactly the patient they don't reach. That gap is the reason compounded semaglutide became a relevant market in the first place.

How Compounded Semaglutide Pricing Works (and Why It's Cheaper)

Compounded semaglutide is dispensed by state-licensed 503A pharmacies or FDA-registered 503B outsourcing facilities under individual prescriptions. There is no single list price because compounded preparations are patient-specific. Pricing is set by the dispensing pharmacy and the telehealth clinic prescribing the medication.

Typical pricing at LegitScript-certified telehealth providers ranges from approximately $179 to $399 per month. That range depends on the dose (lower starting doses cost less because there's less active ingredient), the duration of the prescription, what clinical services come bundled, and whether you're paying month-to-month or committing to a multi-month plan.

Most bundles include the medication, clinical visits for prescribing and monitoring, the pharmacy dispensing fee, and shipping. Some providers fold in ongoing messaging access and clinical support; others charge separately for asynchronous messaging or additional visits.

One thing I'd push you to be skeptical about: the price you see advertised is not always the price you pay. Hidden costs and price changes after the first month are the most common patient complaints in the compounded space. More on that below.

What HealthRX Charges, and Why the Model Matters

For transparency: HealthRX charges a flat monthly rate that includes the medication, the initial clinical evaluation, ongoing clinical support, and shipping. Pricing is published on the membership page and does not change between the first month and subsequent months. The price varies by dose tier in a documented schedule you see before you commit.

We don't use introductory pricing that increases after month one. We don't require multi-month payment up front. Patients can cancel at any time and won't be charged for medication that hasn't shipped.

I'll be direct about why this matters beyond the obvious consumer-friendliness: a provider that requires three months of payment up front or doubles the price after the first month has a business model structured around patient lock-in. That model often correlates with weaker clinical support after the sale, because the financial incentive to keep you satisfied disappears once they have your money. The pricing model is itself a clinical quality signal.

For more on evaluating telehealth providers, see our cluster hub on compounded GLP-1 telehealth providers.

The Costs Nobody Tells You About

Beyond the monthly medication price, semaglutide therapy involves several expenses that catch patients off guard.

Baseline labs. Most clinics require a comprehensive metabolic panel, hemoglobin A1c, thyroid stimulating hormone, and sometimes a lipid panel before initiating therapy. With insurance, these are usually covered with a copay. Cash-pay, expect $100 to $300 at a direct-to-consumer lab service.

Follow-up labs. Typically every three to six months during therapy. Same cost considerations.

Injection supplies. Syringes and alcohol swabs are usually included in the medication shipment, but confirm this. Some providers bill them separately, and that $8 to $15 per month adds up.

Sharps disposal. Small but real. An FDA-cleared sharps container runs $5 to $15 at most pharmacies. Many municipalities offer free or low-cost sharps disposal programs.

The one nobody budgets for: urgent care. Most side effects are mild and managed at home. But emergency department visits for severe dehydration from GI symptoms do happen, and those are not covered by your monthly subscription fee. If you're on a high-deductible health plan, a single ER visit for IV fluids could cost you $800 to $2,000 out of pocket.

For a detailed breakdown, see our supporting article on the true monthly cost of semaglutide therapy.

Can Insurance Cover Compounded Semaglutide?

Short answer: almost never directly.

Most commercial insurance plans either exclude compounded preparations entirely or require pre-authorization documenting why the FDA-approved product can't be used. That's a high bar to clear when the FDA-approved product exists and is available (just expensive).

The workaround some patients use: HSAs and FSAs. If your prescription is documented for a medical indication, you may be able to use these funds toward compounded semaglutide. Eligibility is determined by your plan administrator. Keep itemized receipts and a clinical letter on file in case of audit.

The most common path to insurance-covered GLP-1 therapy remains coverage of the branded product (Wegovy or Ozempic) rather than the compounded preparation. If your plan covers the branded product, that's almost always the cheaper option. Compounded semaglutide is most cost-relevant for patients whose insurance doesn't cover the branded product at all.

A Useful (Imperfect) Frame: Cost Per Pound

Some patients find it helpful to think in terms of cost per pound of weight lost. Using the STEP-1 mean of 14.9 percent body weight loss over 68 weeks at the 2.4 mg dose, a 250-pound patient would lose approximately 37 pounds. At a compounded monthly cost of $250, the total drug cost over 68 weeks is roughly $4,000, or about $108 per pound lost.

This frame has obvious limits. Weight loss isn't the only outcome. The SELECT trial (Lincoff et al., NEJM 2023) showed a 20 percent reduction in major adverse cardiovascular events at the same dose. Sleep apnea improvement, knee pain reduction, and metabolic marker changes all have independent clinical value that a cost-per-pound calculation ignores.

But if you're sitting at your kitchen table like Diane, trying to figure out whether this fits your budget, cost per pound at least gives you a number you can compare to bariatric surgery cost per pound, commercial weight-loss program cost per pound, or doing nothing and paying the ongoing cost of obesity-related comorbidities (which, for what it's worth, nobody ever calculates, even though it's the most expensive option of all).

Why "I'll Just Do Six Months" Is Usually a Bad Plan

Here's the thing most patients don't want to hear. The STEP-4 data (Rubino et al., JAMA 2021) show that weight regain after semaglutide discontinuation is substantial. Patients who stopped after 20 weeks of titration regained 6.9 percent of body weight over the next 48 weeks. Patients who continued lost an additional 7.9 percent. The biological mechanism is straightforward: GLP-1 signaling suppresses appetite, and stopping the drug removes that signal. Your brain doesn't forget it was hungry.

The cost implication is blunt: for most patients, semaglutide is a long-term medication. Budgeting for only a six-month course and planning to maintain results without ongoing therapy is not consistent with the published evidence. I'd argue it's the most common planning mistake patients make, and it's partly the industry's fault for not being explicit about it.

If you can only afford a short course, that doesn't mean you shouldn't start. It means you should have that conversation with your clinician up front so the dose, the duration, and the post-discontinuation plan are designed around the budget constraint rather than discovered after the fact. Some patients use lower-dose or extended-interval maintenance to reduce ongoing cost. This is an off-label approach with limited evidence, and it should be individualized with your prescriber.

For more on long-term planning, see our cluster hub on long-term and maintenance.

State-by-State Access: Not Every Provider Ships Everywhere

Compounded semaglutide telehealth providers operate under state-by-state telemedicine and pharmacy regulations. Not every provider is licensed in every state, and not every 503A pharmacy ships to every state. If you're in a state with restrictive telemedicine licensure, your options may be narrower than you expect.

HealthRX is currently licensed in 44 US states. For patients in other states, look for LegitScript-certified providers licensed in your jurisdiction. LegitScript certification is the single most useful starting filter because it verifies pharmacy licensure, clinician licensure, and compliance with state regulations. Providers without it aren't necessarily illegitimate, but the absence of certification means you're doing the verification work yourself, and most patients aren't equipped to do that thoroughly.

For a guide on verifying a provider before signing up, see our supporting article on how to verify a telehealth GLP-1 provider.

This hub is part of the Compounded Semaglutide Cost and Access cluster. Related supporting articles include:

For the foundational overview, return to the pillar guide.

Frequently Asked Questions

How much does Wegovy cost without insurance? The list price for Wegovy is approximately $1,349 per 28-day supply at the maintenance dose. Without insurance or manufacturer savings cards, this is what you'll pay at the pharmacy counter. Compounded semaglutide alternatives typically range from $179 to $399 per month through telehealth providers.

Does Medicare cover Wegovy for weight loss? No. Federal statute excludes coverage of weight-loss drugs under Medicare Part D. This exclusion has been debated in Congress but remains in effect as of mid-2026. Medicare Part D does cover Ozempic for type 2 diabetes when the patient meets the indication.

Can I use my HSA or FSA to pay for compounded semaglutide? Potentially, yes. If the prescription is documented for a medical indication, many HSA and FSA plans will reimburse for compounded semaglutide. Check with your plan administrator and keep itemized receipts and a clinical letter on file.

Why is compounded semaglutide cheaper than Wegovy? Compounded preparations don't carry the brand-name markup, marketing costs, or the same supply chain structure as FDA-approved products. They are dispensed by state-licensed 503A pharmacies or FDA-registered 503B outsourcing facilities, and pricing is set by the dispensing pharmacy and prescribing clinic rather than by the manufacturer.

What hidden costs should I budget for with semaglutide therapy? Plan for baseline labs ($100 to $300 cash-pay), follow-up labs every three to six months, sharps disposal containers ($5 to $15), and the possibility of an urgent care or ER visit for side effects like severe dehydration. Confirm whether injection supplies are included in your monthly price.

How long do I need to budget for semaglutide therapy? The clinical evidence (STEP-1, STEP-4) supports at least 12 to 16 months for full weight loss benefit, and the data on discontinuation show significant regain. Most patients should plan for long-term use. If your budget only supports a shorter course, discuss this with your clinician up front to plan accordingly.

Is compounded semaglutide covered by insurance? In most cases, no. Commercial plans typically exclude compounded preparations or require pre-authorization documenting why the FDA-approved product cannot be used. The most common path to insurance-covered GLP-1 therapy is coverage of branded Wegovy or Ozempic, not the compounded version.

Not FDA-approved. HealthRX is not a medical practice. Information on this site is for educational purposes and is not a substitute for individualized medical advice. Treatment decisions are made between you and a licensed clinician. Compounded semaglutide is dispensed by state-licensed 503A pharmacies and FDA-registered 503B outsourcing facilities under individual prescriptions. Pricing referenced is approximate and subject to change. References: STEP-1 (Wilding et al., NEJM 2021), STEP-4 (Rubino et al., JAMA 2021), SELECT (Lincoff et al., NEJM 2023).